Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments

Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments

US Patent 11427569 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Coated lithium-ion sieve and preparation method thereof2025
Sirtuin 6 protein deacylase (SIRT6) activators2025
Short-distance optical amplification module, amplification method and amplificat2023
Synthesis of small molecule histone deacetylase 6 degraders, compounds formed th2021
Synthesis of small molecule histone deacetylase 6 degraders, compounds formed th2021
Synthesis of small molecule histone deacetylase 6 degraders, compounds formed th2021
Synthesis of small molecule histone deacetylase 6 degraders, compounds formed th2021
Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed the2020
Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed the2020
Alpha/beta-polypeptide analogs of glucagon-like peptide 12020
Alpha/beta-polypeptide analogs of glucagon-like peptide 12020
Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and ph2019